Akoya Biosciences Financials

Earnings View

Profitability View

Liquidity View

Fundamentals View

Competition View

Akoya Biosciences Stock Summary

Akoya Biosciences competes with AtriCure, ICU Medical, Haemonetics, AngioDynamics, and AptarGroup. Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research in North America, the Asia Pacific, Europe, the Middle East, and Africa. The company was incorporated in 2015 and is headquartered in Marlborough, Massachusetts. Akoya Biosciences operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 319 people.

Akoya Biosciences Key Financial Ratios

Akoya Biosciences Key Balance Sheet Accounts

Akoya Biosciences Key Income Statement Accounts

Akoya Biosciences Key Cash Accounts

Akoya Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Akoya Biosciences's current stock value. Our valuation model uses many indicators to compare Akoya Biosciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Akoya Biosciences competition to find correlations between indicators driving Akoya Biosciences's intrinsic value. More Info.Akoya Biosciences is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . At present, Akoya Biosciences' Return On Equity is projected to drop slightly based on the last few years of reporting. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Akoya Biosciences' earnings, one of the primary drivers of an investment's value.

Akoya Biosciences Systematic Risk

Today, most investors in Akoya Biosciences Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Akoya Biosciences' growth ratios. Consistent increases or decreases in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's growth growth rates may not be enough to decide which company is a better investment. That's why investors frequently use static breakdown of Akoya Biosciences growth as a starting point in their analysis.

Along with financial statement analysis, the daily predictive indicators of Akoya Biosciences help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Akoya Biosciences. We use our internally-developed statistical techniques to arrive at the intrinsic value of Akoya Biosciences based on widely used predictive technical indicators. In general, we focus on analyzing Akoya Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Akoya Biosciences's daily price indicators and compare them against related drivers.

When running Akoya Biosciences' price analysis, check to measure Akoya Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Akoya Biosciences is operating at the current time. Most of Akoya Biosciences' value examination focuses on studying past and present price action to predict the probability of Akoya Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Akoya Biosciences' price. Additionally, you may evaluate how the addition of Akoya Biosciences to your portfolios can decrease your overall portfolio volatility.